Inactive Instrument
Sector Taro Pharmaceutical Industries Ltd. Other OTC
Stocks
IL0010827181
Pharmaceuticals
|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 06-30 | FDA Grants Tentative Approval for ANDA 212581 Azelaic Acid Topical Foam | CI |
| 24-06-24 | Taro Pharmaceutical Industries Ltd.(NYSE:TARO) dropped from S&P Global BMI Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.01% | +1.24% | +0.85% | -3.68% | +10.23% | +63.06% | +120.55% | +414.25% | +1,385.62% | 1,056B | |
| -1.61% | -0.60% | -0.18% | +3.50% | +29.29% | +47.32% | +71.79% | +63.13% | +128.17% | 645B | |
| -1.12% | -0.72% | +3.06% | +3.53% | +15.23% | +17.98% | +76.63% | +141.91% | +319.12% | 465B | |
| +0.84% | -2.97% | -0.11% | +5.89% | +7.37% | +35.59% | +42.07% | +3.06% | +46.22% | 335B | |
| +1.03% | +4.05% | -0.73% | -3.33% | +11.64% | +22.21% | +31.05% | +59.26% | +60.16% | 275B | |
| +0.30% | +0.47% | +4.40% | -11.43% | -9.44% | +11.68% | +14.05% | +39.41% | +149.56% | 255B | |
| +1.32% | +3.27% | -2.03% | +17.50% | +29.43% | +54.63% | +57.63% | +97.13% | +156.05% | 229B | |
| -0.61% | -0.91% | +3.84% | +19.75% | +23.25% | +34.33% | +101.87% | +113.25% | +94.30% | 188B | |
| -0.32% | -0.56% | -14.21% | -20.26% | -22.87% | -27.22% | -60.61% | -19.26% | +82.17% | 169B | |
| 0.00% | +2.83% | +2.72% | +17.85% | +15.34% | +20.42% | -13.42% | -34.02% | -13.81% | 164B | |
| -0.18% | +2.28% | -2.76% | +5.42% | +16.18% | +33.24% | +51.47% | +189.06% | +519.68% | 134B | |
| -1.60% | +0.98% | -5.59% | +7.34% | +16.54% | +42.38% | +8.30% | +3.70% | +16.69% | 128B | |
| +0.86% | -0.82% | -0.05% | -5.58% | +2.52% | +18.80% | +26.04% | +6.61% | -8.92% | 98.21B | |
| +0.71% | -1.55% | -6.29% | -4.13% | -12.98% | -8.36% | -29.31% | -13.36% | +6.42% | 97.03B | |
| +2.12% | -6.39% | -9.95% | -17.37% | -24.48% | -3.46% | +37.30% | +51.72% | +413.76% | 63.61B | |
| +0.71% | -1.78% | +0.26% | +12.12% | +19.54% | +33.95% | +26.31% | +56.26% | +19.84% | 58.12B | |
| +1.11% | +0.04% | +0.59% | +1.90% | +33.29% | +74.74% | +9.95% | +4.95% | -44.84% | 54.41B | |
| +2.39% | +0.73% | +7.59% | +31.21% | +39.15% | +98.95% | +291.06% | +305.40% | -22.03% | 46.39B | |
| +2.59% | -0.22% | -3.59% | -13.81% | -23.42% | -34.08% | +1.51% | -8.61% | +180.13% | 44.75B | |
| Average | +0.54% | -0.80% | -1.17% | +2.44% | +9.25% | +28.22% | +45.49% | +77.57% | +183.59% | 237.07B | |
| Weighted average by Cap. | +0.32% | +0.08% | -0.16% | +1.47% | +12.26% | +36.41% | +62.39% | +144.72% | +429.08% |
- Stock Market
- Stocks
- TARO Stock
- Stock
- Sector Taro Pharmaceutical Industries Ltd.
Select your edition
All financial news and data tailored to specific country editions
